Therapy Areas: Oncology
Varian launches IntelliBlate in Europe, expanding image-guided microwave ablation for cancer care
15 July 2025 - Varian, a Siemens Healthineers (ETR:SHL) company, on Tuesday announced the European launch of IntelliBlate, a CE-marked microwave ablation solution for soft tissue tumour treatment.Inte...
Imugene announces Azer-cel Phase 1b clinical trial data
14 July 2025 - Imugene Limited (ASX: IMU), an Australia-based, clinical-stage immuno-oncology company, announced on Monday new data from its Phase 1b clinical trial evaluating azer-cel (azercabtagene ...
CARsgen successfully defends European GPC3 CAR-T patent
14 July 2025 - CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a China-based company involved in developing innovative CAR T-cell therapies, announced on Sunday a favourable outcome in op...
Oncolytics Biotech to host key opinion leader webinar focusing on pancreatic and gastrointestinal cancers
11 July 2025 - Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), a Canada-based clinical-stage company specialising in immunotherapy for oncology, announced on Thursday that it will host a key opinion ...
IGI and AbbVie enter global licensing agreement for ISB 2001
11 July 2025 - IGI Therapeutics SA, a wholly owned subsidiary of clinical-stage biotechnology company Ichnos Glenmark Innovation Inc (IGI), and pharmaceutical company AbbVie (NYSE:ABBV) announced on T...
European Commission approves TEVIMBRA with chemotherapy for first-line treatment of nasopharyngeal carcinoma
10 July 2025 - Oncology company BeOne Medicines Ltd (NASDAQ:ONC) (HKEX:06160) (SSE:688235) announced on Thursday that the European Commission has approved TEVIMBRA (tislelizumab) in combination with g...